Absence or deficiency of dopamine, serotonin, oxytocin, anhedonia and endorphins

By

Understanding Anhedonia: Types, Causes, and Neurochemical Factors

Anhedonia is the diminished ability to experience pleasure, enjoyment, or satisfaction from activities that would normally be rewarding. It is a common symptom associated with depression, trauma-related disorders, chronic stress, substance use disorders, and various neurological conditions. People experiencing anhedonia often describe feeling emotionally numb, disconnected, or unable to enjoy life as they once did.

Types of Anhedonia

Anhedonia can manifest in several distinct ways:

Anticipatory Anhedonia
This involves difficulty feeling excitement, motivation, or anticipation for upcoming events or activities. Individuals may intellectually understand that something should be enjoyable but feel no emotional enthusiasm or desire to participate.

Consummatory Anhedonia
This is the inability to experience pleasure during an activity that was previously enjoyable. For example, a person may eat their favorite meal yet derive little or no enjoyment from the taste, feeling emotionally detached from the experience.

Social Anhedonia
Social anhedonia is characterized by a lack of interest in social interaction and an inability to feel connected, fulfilled, or emotionally engaged during interactions with others. Relationships may feel distant, and social activities may seem unrewarding.

Why Anhedonia Happens

At its core, anhedonia is linked to disruptions within the brain's reward system, which regulates motivation, pleasure, learning, and reinforcement. This system relies on complex interactions between several neurotransmitters and hormones that help create feelings of enjoyment, accomplishment, connection, and well-being.

When reward pathways—particularly those involving dopamine—are not functioning optimally, the brain may struggle to register positive experiences. As a result, the normal "feel-good" feedback loop becomes impaired. This does not mean the brain is permanently damaged; rather, the signaling systems responsible for generating pleasure and motivation are not operating effectively.

Several key neurochemicals play important roles in emotional well-being and reward processing:

Dopamine

Dopamine is often referred to as the brain's "motivation and reward" neurotransmitter. It is essential for pleasure, goal-directed behavior, learning, and movement.

A dopamine deficiency may contribute to:

  • Depression and persistent low mood
  • Anhedonia and loss of interest in enjoyable activities
  • Reduced motivation and drive
  • Chronic fatigue and sleep disturbances
  • Cognitive difficulties involving memory, attention, and decision-making
  • Motor symptoms such as tremors, rigidity, and balance problems in conditions like Parkinson's disease

Primary Sources:
Substantia nigra and ventral tegmental area (VTA) of the midbrain.

Serotonin

Serotonin helps regulate mood, sleep, appetite, digestion, and emotional stability.

Low serotonin levels may be associated with:

  • Depression and anxiety disorders
  • Insomnia and disrupted sleep patterns
  • Irritability and mood instability
  • Digestive issues, including irritable bowel syndrome (IBS)
  • Problems with memory, learning, and concentration

Primary Source:
Raphe nuclei located within the brainstem.

Oxytocin

Often called the "bonding" or "love hormone," oxytocin plays a critical role in social attachment, trust, empathy, and emotional connection.

A deficiency may contribute to:

  • Social anxiety and discomfort in relationships
  • Emotional detachment or difficulty experiencing closeness
  • Reduced empathy and social bonding
  • Increased stress and reduced resilience
  • Trust and attachment difficulties
  • Postpartum depression in some new mothers

Primary Source:
Produced in the hypothalamus and released through the posterior pituitary gland.

Endorphins

Endorphins are the body's natural pain-relieving chemicals and contribute to feelings of pleasure, relaxation, and emotional well-being.

Low endorphin levels may lead to:

  • Increased sensitivity to physical pain
  • Depression and reduced enjoyment of life
  • Elevated stress levels
  • Poor stress management and emotional regulation
  • Greater vulnerability to substance misuse
  • Frequent mood fluctuations

Primary Sources:
Hypothalamus and pituitary gland.

The Interconnected Nature of Neurotransmitters

While dopamine is often highlighted in discussions of anhedonia, pleasure and emotional well-being depend on a complex network of neurotransmitters and hormones working together. Dopamine influences motivation and reward; serotonin supports mood stability; oxytocin fosters connection and trust; and endorphins contribute to comfort, resilience, and pleasure.

When one or more of these systems become dysregulated—due to chronic stress, trauma, depression, neurological illness, substance use, inflammation, or other biological factors—the ability to experience joy, satisfaction, motivation, and emotional connection can be significantly diminished.

Treatment and Recovery

Anhedonia is often treatable, especially when its underlying causes are identified and addressed. Treatment approaches may include:

  • Psychotherapy (such as Cognitive Behavioral Therapy, trauma-focused therapy, or Acceptance and Commitment Therapy)
  • Medications that target neurotransmitter imbalances
  • Regular physical exercise, which can increase dopamine and endorphin activity
  • Improved sleep hygiene and stress management
  • Social connection and meaningful engagement with others
  • Nutritional interventions and, when appropriate, dietary supplementation
  • Treatment of underlying medical, neurological, or psychiatric conditions

Recovery is often gradual. As neurotransmitter systems begin functioning more effectively and underlying conditions improve, many individuals regain the ability to experience pleasure, motivation, emotional connection, and a renewed sense of purpose.

Lecture by Robert Sapolsky: The Biology and Psychology of Depression
 (start at 1:11.08) https://www.youtube.com/watch?v=fzUXcBTQXKM&t=4875s

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a five-year copyright. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9 

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  Abstract To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1. These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the signi...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. Acids, whether from external sources (like industrial chemicals) or internal imbalances (such as metabolic disorders), can have profound effects on both the muscular and vascular systems.   Exposure to strong acids or acid imbalances in the body can disrupt cellular function, cause tissue damage, and lead to systemic health problems. This article explores how acids can negatively impact muscular and vascular health, with an emphasis on both external exposure to corrosive acids and internal acid imbalances caused by metabolic disorders or genetic conditions. Since not everyone is affected by ME/CFS or COVID, it could be beneficial to test for genetic predispositions, such as amino acids, particularly fatty acids. 1. External Acid Exposure and Its Effects on Muscular and Vascular Systems 1.1. Muscular Effects Muscle tissue is highly sensitive to changes in pH, and exposure to strong acids ca...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more